Table 3

Number of asthma patients receiving different types of asthma medication before the new oral β-blocker (n=1171)

MedicationNo. of patients receiving medications (%)
SABA847 (72.3)
LABA89 (7.6)
ICS614 (52.4)
LABA/ICS154 (13.1)
Leukotriene antagonist32 (2.7)
Theophylline10 (0.9)
  • ICS, inhaled corticosteroid; LABA, long-acting β-agonist; SABA, short-acting β-agonist.